Titre : Interactions microbiennes

Interactions microbiennes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Double-Blind Method
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Interactions microbiennes : Questions médicales les plus fréquentes", "headline": "Interactions microbiennes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Interactions microbiennes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-01", "dateModified": "2025-02-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Interactions microbiennes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénomènes microbiologiques", "url": "https://questionsmedicales.fr/mesh/D008827", "about": { "@type": "MedicalCondition", "name": "Phénomènes microbiologiques", "code": { "@type": "MedicalCode", "code": "D008827", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G06" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Détection du quorum", "alternateName": "Quorum Sensing", "url": "https://questionsmedicales.fr/mesh/D053038", "about": { "@type": "MedicalCondition", "name": "Détection du quorum", "code": { "@type": "MedicalCode", "code": "D053038", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G06.550.700" } } } ], "about": { "@type": "MedicalCondition", "name": "Interactions microbiennes", "alternateName": "Microbial Interactions", "code": { "@type": "MedicalCode", "code": "D056265", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rachel J Dutton", "url": "https://questionsmedicales.fr/author/Rachel%20J%20Dutton", "affiliation": { "@type": "Organization", "name": "School of Biological Science, University of California San Diego, San Diego, 92093, USA. rjdutton@ucsd.edu." } }, { "@type": "Person", "name": "Ophelia S Venturelli", "url": "https://questionsmedicales.fr/author/Ophelia%20S%20Venturelli", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706." } }, { "@type": "Person", "name": "Alan R Pacheco", "url": "https://questionsmedicales.fr/author/Alan%20R%20Pacheco", "affiliation": { "@type": "Organization", "name": "Graduate Program in Bioinformatics and Biological Design Center, Boston University, 24 Cummington Mall, Boston, MA, 02215, USA." } }, { "@type": "Person", "name": "Daniel Segrè", "url": "https://questionsmedicales.fr/author/Daniel%20Segr%C3%A8", "affiliation": { "@type": "Organization", "name": "Graduate Program in Bioinformatics and Biological Design Center, Boston University, 24 Cummington Mall, Boston, MA, 02215, USA." } }, { "@type": "Person", "name": "Kai Feng", "url": "https://questionsmedicales.fr/author/Kai%20Feng", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Environmental Biotechnology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evaluating the effectiveness of stromal-vascular fraction (SVF) cells along with subcision method in the treatment of acne scars: A double-blind randomized controlled clinical trial study.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36086927", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jocd.15375" } }, { "@type": "ScholarlyArticle", "name": "ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.", "datePublished": "2022-12-20", "url": "https://questionsmedicales.fr/article/36600424", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-067251" } }, { "@type": "ScholarlyArticle", "name": "Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.", "datePublished": "2022-05-23", "url": "https://questionsmedicales.fr/article/35617986", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2213-2600(22)00088-1" } }, { "@type": "ScholarlyArticle", "name": "Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial.", "datePublished": "2024-08-14", "url": "https://questionsmedicales.fr/article/39161682", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/DDDT.S472651" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of Liposomal Melatonin in sleep EEG in Childhood: A Double Blind Case Control Study.", "datePublished": "2022-12-29", "url": "https://questionsmedicales.fr/article/36612875", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20010552" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes microbiologiques", "item": "https://questionsmedicales.fr/mesh/D008827" }, { "@type": "ListItem", "position": 3, "name": "Interactions microbiennes", "item": "https://questionsmedicales.fr/mesh/D056265" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Interactions microbiennes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Interactions microbiennes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Interactions microbiennes", "description": "Comment diagnostiquer une dysbiose microbienne ?\nQuels tests sont utilisés pour identifier les interactions microbiennes ?\nQuels signes indiquent une infection microbienne ?\nComment évaluer la diversité microbienne ?\nQuels marqueurs biologiques sont utilisés pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Double-Blind+Method&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Interactions microbiennes", "description": "Quels symptômes sont liés aux déséquilibres microbiens ?\nComment les interactions microbiennes affectent-elles la santé ?\nQuels symptômes indiquent une infection opportuniste ?\nLes allergies peuvent-elles être liées aux interactions microbiennes ?\nQuels signes cliniques sont associés aux infections bactériennes ?", "url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Double-Blind+Method&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Interactions microbiennes", "description": "Comment prévenir les infections microbiennes ?\nLes probiotiques peuvent-ils prévenir les infections ?\nQuelles mesures d'hygiène sont recommandées ?\nComment l'alimentation influence-t-elle la santé microbienne ?\nLes vaccinations aident-elles à prévenir les infections ?", "url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Double-Blind+Method&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Interactions microbiennes", "description": "Quels traitements sont efficaces contre les infections microbiennes ?\nComment les probiotiques influencent-ils les interactions microbiennes ?\nQuels sont les traitements pour la dysbiose ?\nLes antibiotiques affectent-ils la flore microbienne ?\nComment les traitements immunomodulateurs agissent-ils ?", "url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Double-Blind+Method&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Interactions microbiennes", "description": "Quelles complications peuvent survenir avec une dysbiose ?\nComment les infections microbiennes peuvent-elles devenir chroniques ?\nQuels risques sont associés aux infections opportunistes ?\nLes déséquilibres microbiens peuvent-ils affecter la santé mentale ?\nQuelles complications peuvent résulter d'un traitement antibiotique inapproprié ?", "url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Double-Blind+Method&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Interactions microbiennes", "description": "Quels facteurs augmentent le risque d'infections microbiennes ?\nComment le stress influence-t-il les interactions microbiennes ?\nL'alimentation joue-t-elle un rôle dans les infections ?\nQuels médicaments peuvent perturber la flore microbienne ?\nLes voyages peuvent-ils augmenter le risque d'infections ?", "url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Double-Blind+Method&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysbiose microbienne ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par analyse des échantillons microbiens et évaluation des symptômes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier les interactions microbiennes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture, séquençage ADN et métagénomique sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une infection microbienne ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, inflammation, douleur et fatigue sont des signes courants d'infection." } }, { "@type": "Question", "name": "Comment évaluer la diversité microbienne ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par des méthodes de séquençage et d'analyse statistique." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont utilisés pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs incluent les cytokines, les métabolites et les biomarqueurs spécifiques." } }, { "@type": "Question", "name": "Quels symptômes sont liés aux déséquilibres microbiens ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent troubles digestifs, fatigue, et infections récurrentes." } }, { "@type": "Question", "name": "Comment les interactions microbiennes affectent-elles la santé ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des maladies, influencer l'immunité et le métabolisme." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection opportuniste ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, éruptions cutanées et infections persistantes peuvent indiquer une infection opportuniste." } }, { "@type": "Question", "name": "Les allergies peuvent-elles être liées aux interactions microbiennes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines interactions peuvent moduler la réponse immunitaire et provoquer des allergies." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés aux infections bactériennes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, gonflement et douleur sont des signes cliniques d'infections bactériennes." } }, { "@type": "Question", "name": "Comment prévenir les infections microbiennes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène, se faire vacciner et éviter les contacts à risque." } }, { "@type": "Question", "name": "Les probiotiques peuvent-ils prévenir les infections ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les probiotiques peuvent renforcer la barrière intestinale et prévenir certaines infections." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et désinfecter les surfaces sont essentielles." } }, { "@type": "Question", "name": "Comment l'alimentation influence-t-elle la santé microbienne ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fibres et en probiotiques favorise une flore microbienne saine." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir les infections ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations protègent contre certaines infections bactériennes et virales." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre les infections microbiennes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques, antifongiques et antiviraux sont utilisés selon le type d'infection." } }, { "@type": "Question", "name": "Comment les probiotiques influencent-ils les interactions microbiennes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques rétablissent l'équilibre microbien et améliorent la santé intestinale." } }, { "@type": "Question", "name": "Quels sont les traitements pour la dysbiose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des probiotiques, prébiotiques et modifications alimentaires." } }, { "@type": "Question", "name": "Les antibiotiques affectent-ils la flore microbienne ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antibiotiques peuvent perturber la flore microbienne normale, causant des déséquilibres." } }, { "@type": "Question", "name": "Comment les traitements immunomodulateurs agissent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Ils modifient la réponse immunitaire pour aider à contrôler les infections microbiennes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une dysbiose ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des maladies inflammatoires, allergies et infections chroniques." } }, { "@type": "Question", "name": "Comment les infections microbiennes peuvent-elles devenir chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent persister si le système immunitaire est affaibli ou mal géré." } }, { "@type": "Question", "name": "Quels risques sont associés aux infections opportunistes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les infections opportunistes peuvent entraîner des complications graves, surtout chez les immunodéprimés." } }, { "@type": "Question", "name": "Les déséquilibres microbiens peuvent-ils affecter la santé mentale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent un lien entre déséquilibres microbiens et troubles mentaux." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'un traitement antibiotique inapproprié ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Cela peut entraîner des résistances bactériennes et des infections secondaires." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infections microbiennes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, le diabète, l'immunodépression et une mauvaise hygiène augmentent le risque." } }, { "@type": "Question", "name": "Comment le stress influence-t-il les interactions microbiennes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut altérer la flore intestinale et affaiblir le système immunitaire." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans les infections ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut affaiblir l'immunité et favoriser les infections." } }, { "@type": "Question", "name": "Quels médicaments peuvent perturber la flore microbienne ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques, les anti-inflammatoires et les immunosuppresseurs peuvent perturber la flore." } }, { "@type": "Question", "name": "Les voyages peuvent-ils augmenter le risque d'infections ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages exposent à de nouveaux agents pathogènes et augmentent le risque d'infections." } } ] } ] }

Sources (10000 au total)

Evaluating the effectiveness of stromal-vascular fraction (SVF) cells along with subcision method in the treatment of acne scars: A double-blind randomized controlled clinical trial study.

Subcision method is one of the main techniques for treatment of acne scars or stromal-vascular fraction (SVF) and combined therapy can improve treatment strategy.... To use subcision method along with SVF for treatment of acne scar and comprised with alone subcision method.... In this double-blind clinical trial study, 10 patients with acne scars were entered into the study. Subcision technique was randomly performed on one side of the face and subcision technique plus SVF ... In terms of volume and area of scars, the mean percent change was 46.55 ± 13.92 and 44.60 ± 5.76, for the case group, and 13.31 ± 9.27 and 11.28 ± 9.64 for the control group, respectively. So, combine... According to the acquired results, combined therapy can be considered as effective and safe treatment for acne scars with significant higher efficacy compared with subcision alone....

ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.

Sepsis is a major cause of death among hospitalised patients. Accumulating evidence suggests that immune response during sepsis cascade lies within a spectrum of dysregulated host responses. On the on... ImmunoSep is a randomised placebo-controlled phase 2 clinical trial with a double-dummy design in which the effect of precision immunotherapy on sepsis phenotypes with MALS and immunoparalysis is stud... The protocol is approved by the German Federal Institute for Drugs and Medical Devices; the National Ethics Committee of Greece and by the National Organization for Medicines of Greece; the Central Co... NCT04990232....

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone p... In this randomised, double-blind, double placebo-controlled trial, patients were enrolled at 67 trial sites in the USA (60 sites), South Korea (two sites), Mexico (two sites), Singapore (two sites), a... Between Dec 1, 2020, and April 13, 2021, 1047 patients were assessed for eligibility. 1010 patients were enrolled and randomly assigned, 516 (51%) to baricitinib plus remdesivir plus placebo and 494 (... In hospitalised patients with COVID-19 requiring supplemental oxygen by low-flow, high-flow, or non-invasive ventilation, baricitinib plus remdesivir and dexamethasone plus remdesivir resulted in simi... National Institute of Allergy and Infectious Diseases....

Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial.

This study aimed to establish the 95% effective dose (ED95) of esketamine in combination with propofol for hysteroscopy and then to evaluate its efficacy and safety profile.... This prospective, double-blind, randomized controlled trial consisted of two cohorts. In cohort 1, 45 women aged 18-65 years undergoing hysteroscopy were randomly assigned to either group E (esketamin... The ED95 of esketamine was 0.254 mg/kg (95% CI: 0.214-1.004), while that of alfentanil was 9.121 μg/kg (95% CI: 8.479-13.364). The anesthesia success rate was 93.0% in group E and 95.2% in group A (p ... This study determined the ED 95 dose of esketamine for intravenous general anesthesia during hysteroscopy. Esketamine showed less respiratory and hemodynamic depression, as well as fewer adverse effec... www.chictr.org.cn, (ChiCTR2300077283); registered November 3, 2023....

A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.

Rescue of mitochondrial function is a promising neuroprotective strategy for Parkinson's disease (PD). Ursodeoxycholic acid (UDCA) has shown considerable promise as a mitochondrial rescue agent across... To investigate the safety and tolerability of high-dose UDCA in PD and determine midbrain target engagement.... The UP (UDCA in PD) study was a phase II, randomized, double-blind, placebo-controlled trial of UDCA (30 mg/kg daily, 2:1 randomization UDCA vs. placebo) in 30 participants with PD for 48 weeks. The p... UDCA was safe and well tolerated, and only mild transient gastrointestinal adverse events were more frequent in the UDCA treatment group. Midbrain... High-dose UDCA is safe and well tolerated in early PD. Larger trials are needed to further evaluate the disease-modifying effect of UDCA in PD. © 2023 The Authors. Movement Disorders published by Wile...

Intravenous vitamin C for vasoplegia: A double-blinded randomised clinical trial (VALENCIA trial).

To determine whether intravenous vitamin C compared with placebo, reduces vasopressor requirements in patients with vasoplegic shock.... Double-blinded, randomised clinical trial (RCT) conducted in two intensive care units in Perth, Australia. Vasopressor requirements at enrolment needed to be >10 μg/min noradrenaline after hypovolaemi... Of the 71 patients randomised (35 vitamin C, 36 placebo group), the median vasopressor duration was 44 h [95% CI, 37-54 h] and 55 h [95% CI, 33-66 h]) in the vitamin C and placebo groups (p = 0.057). ... In this RCT of patients with vasoplegic shock of at least moderate severity, the use of IV vitamin C compared with placebo did not significantly reduce the duration of vasopressors.... Prospective registration - trial number ACTRN12617001392358....

Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety.

Fibrotic hypersensitivity pneumonitis (FHP) is an irreversible lung disease with high morbidity and mortality. We sought to evaluate the safety and effect of pirfenidone on disease progression in such... We conducted a single-centre, randomised, double-blinded, placebo-controlled trial in adults with FHP and disease progression. Patients were assigned in a 2:1 ratio to receive either oral pirfenidone ... After randomising 40 patients, enrolment was interrupted by the COVID-19 pandemic. There was no significant between-group difference in FVC% at week 52 (mean difference -0.76%, 95% CI -6.34 to 4.82). ... The trial was underpowered to detect a difference in the primary end point. Pirfenidone was found to be safe and improved PFS in patients with FHP.... NCT02958917....

Comparison of intravenous ibuprofen and tenoxicam efficiency in ankle injury: a randomized, double-blind study.

Pain after soft tissue injuries in and around the ankle is a troublesome process in terms of patient comfort and mobilization. The aim of this study was to compare the analgesic efficacy of intravenou... We conducted a prospective, double-blind, randomized controlled study in a tertiary hospital. The patients were divided into two groups as those administered IV 400 mg ibuprofen and IV 20 mg tenoxicam... One hundred and twenty-four patients were included in the study. There were 62 patients in the tenoxicam group and 62 patients in the ibuprofen group. When VAS scores were compared, it was found that ...